Literature DB >> 2659691

Antigen presenting cells.

D L Hamilos1.   

Abstract

A great deal has been learned over the past few years regarding the molecular biology of antigen presentation. These discoveries have been possible in part because of acquisition of protein sequencing data regarding class I and class II MHC molecules and in part because of X-ray crystallographic analysis of the three-dimensional structures of these molecules. These discoveries have merged nicely with detailed immunologic studies delineating the 'minimal antigenic peptides' of complex protein antigens. All of these studies strongly confirm the belief that the antigen-specific interaction of T cells with antigen in the context of antigen presenting cells is exquisitely specific. The process of 'trimolecular complex' formation involves binding interactions between antigenic peptide, class I or class II MHC molecules and the antigen-specific T cell receptor. One of the key functions of antigen presenting cells involves the 'processing' of complex protein antigens so as to allow for the interaction of the 'minimal antigenic peptide' with the appropriate class I or class II MHC molecule. A substantial body of evidence now indicates that the interaction of processed antigenic peptides and class II MHC molecules involves a binding interaction with a significant binding affinity and a slow dissociation constant. In addition to antigen-specific binding interactions which govern antigen presentation, there are a variety of antigen-independent and MHC-independent factors which greatly augment the process of antigen presentation. Along with differences in antigen processing, these factors probably account for the qualitative and quantitative differences seen between the various cell types involved in antigen presentation. There may be a substantial amount of antigen which associates with the antigen presenting cell surface in an MHC-independent fashion associated with so-called 'non-MHC peptide binding structures'. However, if the trimolecular complex theory is to be satisfied, antigen bound to these structures ultimately must become associated with the MHC restricting element in order to effectively engage the antigen-specific T cell receptor. Antigen presenting cells differ in their sensitivity to lymphokines and inflammatory mediators which augment antigen presentation. In addition, antigen presenting cells differ in their capacity to secrete or express membrane-bound costimulatory molecules, such as interleukin 1. Finally, factors which promote the cellular adherence of antigen presenting cells with T cells greatly augment the process of antigen presentation.(ABSTRACT TRUNCATED AT 400 WORDS)

Mesh:

Substances:

Year:  1989        PMID: 2659691     DOI: 10.1007/bf02919073

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  101 in total

Review 1.  Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.

Authors:  T J Braciale; L A Morrison; M T Sweetser; J Sambrook; M J Gething; V L Braciale
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

2.  Capacity of small B cell-enriched populations to stimulate mixed lymphocyte reactions: marked differences between irradiated vs. mitomycin C-treated stimulators.

Authors:  S R Webb; J H Li; D B Wilson; J Sprent
Journal:  Eur J Immunol       Date:  1985-01       Impact factor: 5.532

3.  Spectrum of immunoregulatory functions and properties of human alveolar macrophages.

Authors:  E A Rich; D J Tweardy; H Fujiwara; J J Ellner
Journal:  Am Rev Respir Dis       Date:  1987-08

Review 4.  Antigen presenting cells and mechanisms of antigen presentation.

Authors:  R W Chesnut; H M Grey
Journal:  Crit Rev Immunol       Date:  1985       Impact factor: 2.214

5.  Antigen presentation: comments on its regulation and mechanism.

Authors:  E R Unanue; D I Beller; C Y Lu; P M Allen
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

6.  Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation.

Authors:  T A Chatila; D H Schwartz; R Miller; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1987-08

7.  Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.

Authors:  A Zlotnik; M Fischer; N Roehm; D Zipori
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

8.  Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness.

Authors:  E A Kurt-Jones; S Hamberg; J Ohara; W E Paul; A K Abbas
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

9.  Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

10.  Clustering of dendritic cells, helper T lymphocytes, and histocompatible B cells during primary antibody responses in vitro.

Authors:  K Inaba; M D Witmer; R M Steinman
Journal:  J Exp Med       Date:  1984-09-01       Impact factor: 14.307

View more
  9 in total

1.  Induction of lymphocyte proliferation by antigen-pulsed human neutrophils.

Authors:  C Prior; P J Townsend; D A Hughes; P L Haslam
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice.

Authors:  Hua Li; Steven Tuyishime; Te-Lang Wu; Wynetta Giles-Davis; Dongming Zhou; Weidong Xiao; Katherine A High; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2010-12-14       Impact factor: 11.454

Review 3.  Bacterial Pathogens and the Microbiome.

Authors:  Thad W Vickery; Vijay R Ramakrishnan
Journal:  Otolaryngol Clin North Am       Date:  2017-02       Impact factor: 3.346

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 5.  T cell immunotherapy enhanced by designer biomaterials.

Authors:  Zachary S Dunn; John Mac; Pin Wang
Journal:  Biomaterials       Date:  2019-06-14       Impact factor: 12.479

Review 6.  Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective.

Authors:  Silke Neumann; Nicholas J Shields; Thomas Balle; Mary Chebib; Andrew N Clarkson
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

7.  CpGs Induce Differentiation of Atlantic Salmon Mononuclear Phagocytes Into Cells With Dendritic Morphology and a Proinflammatory Transcriptional Profile but an Exhausted Allostimulatory Activity.

Authors:  Dimitar B Iliev; Leidy Lagos; Hanna L Thim; Sven M Jørgensen; Aleksei Krasnov; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

Review 8.  Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review.

Authors:  Xingliang Fang; Huanrong Lan; Ketao Jin; Daojun Gong; Jun Qian
Journal:  Cancers (Basel)       Date:  2022-08-09       Impact factor: 6.575

9.  Homing of Antigen-Presenting Cells in Head Kidney and Spleen - Salmon Head Kidney Hosts Diverse APC Types.

Authors:  Dimitar B Iliev; Hanna Thim; Leidy Lagos; Randi Olsen; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2013-06-06       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.